Advancements in Small Molecule Drug Formulation has witnessed remarkable progress in recent years including nanotechnology and new improved drug delivery systems.

Samsung Biologics will develop and manufacture drugs for Kurma’s portfolio companies, including by providing CMC drug development.

Before joining Amgen, Dr Tukra got his PhD from Purdue University in Industrial and Physical Pharmacy. While at Purdue he also worked at LyoHUB as an advisor and researcher in industrial and academic projects.

The pharmaceutical industry is increasingly looking for approaches to shorten drug development timelines and save on cost, especially virtual biotech companies who rely heavily on key milestone payments. It is therefore imperative that new chemical entities can be quickly manufactured quickly into clinical drug products.

Tailor-made pharmaceutical development & commercial solutions.

CMC development support, characterisation, stability, and quality control services.

CMC development support, characterisation, stability and quality control services.

Bioanalytical Expertise from Preclinical to Commercialisation

Contract drug development expertise to accelerate your inhaled biomolecule to market.